Source:http://linkedlifedata.com/resource/pubmed/id/17659772
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
31
|
pubmed:dateCreated |
2007-8-21
|
pubmed:abstractText |
Microporous, biocomposite matrices comprising a continuous phase of poly(epsilon-caprolactone) (PCL) and a dispersed phase of lactose or gelatin particles with defined size range (45-90, 90-125 and 125-250 microm) were produced by precipitation casting from solutions of PCL in acetone. Scanning electron microscopy (SEM) analysis revealed a characteristic surface morphology of particulates interspersed amongst crystalline lamellae of the polymer phase. Rapid release of around 80% of the lactose content occurred in PBS at 37 degrees C in 3 days, whereas biocomposites containing gelatin particles of size range 90-125 and 125-250 microm, respectively, displayed gradual and highly efficient release of around 90% of the protein phase over 21 days. A highly porous structure was obtained on extraction of the water-soluble phase. Micro-computed tomography (Micro-CT) and image analysis enabled 3-D visualisation and quantification of the internal pore size distribution. A maximum fractional pore area of 10.5% was estimated for gelatin-loaded matrices. Micro-CT analysis confirmed the presence of an extensive system of macropores, sufficiently connected to permit protein diffusion, but an absence of high volume, inter-pore channels. Thus tissue integration would be confined to the matrix surface initially if the designs investigated were used as tissue-engineering scaffolds, with the core potentially providing a depot system for controlled delivery of growth factors.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Biocompatible Materials,
http://linkedlifedata.com/resource/pubmed/chemical/Delayed-Action Preparations,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Carriers,
http://linkedlifedata.com/resource/pubmed/chemical/Lactose,
http://linkedlifedata.com/resource/pubmed/chemical/Polyesters,
http://linkedlifedata.com/resource/pubmed/chemical/polycaprolactone
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0142-9612
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
28
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
4619-27
|
pubmed:dateRevised |
2008-8-14
|
pubmed:meshHeading |
pubmed-meshheading:17659772-Biocompatible Materials,
pubmed-meshheading:17659772-Delayed-Action Preparations,
pubmed-meshheading:17659772-Diffusion,
pubmed-meshheading:17659772-Drug Carriers,
pubmed-meshheading:17659772-Kinetics,
pubmed-meshheading:17659772-Lactose,
pubmed-meshheading:17659772-Materials Testing,
pubmed-meshheading:17659772-Polyesters,
pubmed-meshheading:17659772-Porosity
|
pubmed:year |
2007
|
pubmed:articleTitle |
Characterisation of the macroporosity of polycaprolactone-based biocomposites and release kinetics for drug delivery.
|
pubmed:affiliation |
Faculty of Pharmacy, Australian Key Centre for Microscopy and Microanalysis, Sutton Arthritis Research Laboratories, Royal North Shore Hospital, University of Sydney, NSW 2006, Australia.
|
pubmed:publicationType |
Journal Article
|